The Precision Medicine Company

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies

AlphaBiomics initiates collaboration with Amsterdam University Medical Centers.

Read more here.

NIHR_Logos_Funded by_COL_CMYK

The Precision Medicine Company

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies

Winner of the 2018 European Innovation Quickfire Challenge (read more)